Effect of radiation therapy on patients with stage T3 or T4 malignant Phyllodes tumors: a retrospective observational study based on SEER

Abstract

Abstract Purpose Among all primary breast tumors, malignant phyllodes tumor of the breast(MPTB) make up less than 1%. In the treatment of phyllode tumors, surgical procedures such as mastectomy and breast-conserving surgery are the mainstay. MPTB has, however, been controversial when it comes to treating it with RT. We aimed to explore the prognostic impact of RT and other clinicopathologic factors on long-term survival for patients with stage T3 or T4 malignant phyllodes tumors. Methods We select patients with stage T3 or T4 MPTB who qualified for the criteria between 2000 and 2018 via the Surveillance, Epidemiology, and End Results (SEER) database. We performed 1:1 propensity score matching (PSM) and Kaplan-Meier analysis to explore the role of RT in long-term survival of patients with stage T3 or T4 MPTB. A univariate and multivariate analysis of OS and BCSS risk factors was carried out using a Cox proportional hazards model. In addition, the nomogram graph of OS and BCSS was constructed. Results A total of 583 patients with stage T3 or T4 malignant Phyllodes tumors were included in this study, of whom 154(26.4%) received RT, and 429(73.6%) were treated without RT. Before adjustment, between groups with and without RT, OS(p = 0.212) and BCSS(p = 0.1) indicated no significant difference respectively. Using of PSM, the two groups still did not differ significantly in OS(p = 0.172) and BCSS(p = 0.552). In multivariate analysis, age, surgery of primary site and distant metastatic status were related to prognosis, while RT still did not affect OS and BCSS. Conclusion Based on the SEER database analysis, the study suggests that the patients with stage T3 or T4 MPTB treated with RT after surgery didn't have significant differences in BCSS or OS compared to those not treated with RT.